Pfizer Inc.'s fourth-quarter profit fell by half due to higher costs for production, administration and restructuring, yet the world's second-biggest drugmaker managed to beat Wall Street expectations.
By LINDA A. JOHNSON, The Southern: Living
Tue, 02/02/2016 - 7:57am
Pfizer Inc.'s fourth-quarter profit fell by half due to higher costs for production, administration and restructuring, yet the world's second-biggest drugmaker managed to beat Wall Street expectations.